Early investors squeezed out in longevity biotech funding deals
Fight Aging! - 03-Sep-2025New funding terms cut early stakes by up to 100-to-1, threatening trust in longevity biotech
Join the club for FREE to access the whole archive and other member benefits.
Track where the serious money is being invested in the longevity industry.
New funding terms cut early stakes by up to 100-to-1, threatening trust in longevity biotech
Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Startup uses AI to explore billions of molecules for next-gen skincare innovation
Click on resource name for more details.
Scotch McClure shares the latest from Maxwell Biosciences
12-Mar-2026
One-day conference for over 350 visitors focused on AI, cybersecurity, and big data (St. Gallen, Switzerland)
Translating Aging podcast episode- Chris and Sergey discuss how investment strategies are driving the future of longevity biotech
22-Sep-2025
Conference gathering longevity experts and investors at one place (Gstaad, Switzerland)
30-Aug-2025
Opportunity to invest in longevity with investors, longevity entrepreneurs, scientists and policy makers (Aix-en-Provence, France)
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science